Clinigen

1.4K posts

Clinigen banner
Clinigen

Clinigen

@Clinigen

Getting the right medicine to the right patient at the right time.

United Kingdom Katılım Mart 2010
1.2K Takip Edilen1.4K Takipçiler
Clinigen
Clinigen@Clinigen·
@AngadSinghChha1 Hi Angad, thanks for getting in touch. We have sent you a private message to follow up with you on your enquiry. Kind regards, Sam (Clinigen Social Media Team)
English
0
0
1
25
Trusting the process
Trusting the process@AngadSinghChha1·
@Clinigen My son has been prescribed Orencia Abatacept (125/250mg) subcutaneous for treatment of LRBA deficiency in Mumbai India.. We are unable to procure the same here..can you please share your arrangements for delivery of the medicine in India.. Query ref 230511-000241
Mumbai, India 🇮🇳 English
1
0
0
51
Clinigen
Clinigen@Clinigen·
We are proud to sponsor an all expert session on the current issues in the optimisation of Asparaginase use in clinical practice at @SIOPEurope, Tuesday 9th May 2023. Register now to join us in Valencia. siopeurope.eu
Clinigen tweet media
English
0
2
5
741
Clinigen
Clinigen@Clinigen·
Clinigen Insights 2023 – We are live! Should Early Access be considered an integral part of a market access strategy? Today and tomorrow, we’ll discuss this key topic and more at our Clinigen Insights event in Basel, Switzerland. #earlyaccess #managedaccess #expandedaccess
Clinigen tweet media
English
0
0
1
288
Clinigen
Clinigen@Clinigen·
We’re pleased to announce that Clinigen has entered into an agreement to divest Lamda Laboratories to Adragos Pharma. Read the press release in full: clinigengroup.com/news/news-cont…
Clinigen tweet media
English
0
0
0
273
Clinigen
Clinigen@Clinigen·
Final call for our free-to-attend 'Clinigen Insights Conference' with keynote speaker Tim Spector, Professor at King’s College London and co-founder of Zoe Ltd.  Have a look at the full event agenda and register to attend: bit.ly/3YnOqk1
Clinigen tweet media
English
0
0
0
218
Clinigen
Clinigen@Clinigen·
Managed Access as part of a commercial strategy - Join our free-of-charge Clinigen Insights event to learn what needs to be considered: bit.ly/3YnOqk1 Guest speakers include Shirle Zajac, Teva, Winston Smit, BristolMyersSquibb, Chris Hoyle & Joubert Gama, Immunocore.
Clinigen tweet media
English
0
0
0
253
Clinigen
Clinigen@Clinigen·
This #InternationalWomensDay2023 we're celebrating the incredible women at Clinigen. With 60% of our global workforce, and 60% of our Clinigen Management Academy graduates, identifying as female, we're immensely proud to provide an inclusive environment where women can thrive.
English
0
0
0
193
Clinigen
Clinigen@Clinigen·
What are the recent changes in trends for #earlyaccess, and how can the updated regulatory framework in countries like France impact your #managedaccess strategy? Join us at our Clinigen Insights conference next month to learn more: bit.ly/3YnOqk1
Clinigen tweet media
English
0
0
0
188
Clinigen
Clinigen@Clinigen·
There are over 300 million people, across the globe, living with rare diseases. That’s 5% of the worldwide population. We are supporting the day by showing our colours and highlighting the great work #rarediseaseday does in helping those across the world.  #rarediseaseday2023
Clinigen tweet media
English
0
0
2
273
Clinigen
Clinigen@Clinigen·
We're delighted to have @timspector,  Professor at King’s College London and co-founder of Zoe Ltd., as keynote speaker at our Clinigen Insight conference in Basel next month: tim-spector.co.uk Learn more about our event and register to join: bit.ly/3YnOqk1
Clinigen tweet media
English
0
0
0
154
Clinigen
Clinigen@Clinigen·
Together with guest speaker @mark_sheehan_ox, Associate Professor at the University of Oxford, we'll discuss how #patientengagement and ethical considerations can be integrated into the planning of a MAP. Join our Clinigen Insights conference next month: bit.ly/3YnOqk1
Clinigen tweet media
English
0
0
2
680
Clinigen
Clinigen@Clinigen·
Clinigen Insights: Together with Florence Barkats, Chief Commercial Officer at CISIV, we will present examples of real-world data collection and how #RealWorldEvidence can add value to market access. Join our Clinigen Insights event to learn more: bit.ly/3YnOqk1
Clinigen tweet media
English
0
0
0
154
Clinigen
Clinigen@Clinigen·
Clinigen is delighted to announce it has entered into an agreement to divest Proleukin® to Iovance Biotherapeutics for £166.7 million. The deal includes a £41.7 million milestone payment and double-digit Proleukin® global sales royalties. Find out more: clinigengroup.com/news/news-cont…
Clinigen tweet media
English
0
0
0
232
Clinigen
Clinigen@Clinigen·
Clinigen is excited to announce they have entered into an agreement with Accord Healthcare to initiate a Managed Access Program in Europe for relugolix (ORGOVYX®). #managedaccess #earlyaccess
Clinigen tweet media
English
0
0
0
206
Clinigen
Clinigen@Clinigen·
Clinigen welcomes the results of the MIROCALS study and is proud of the part one of our medicines played in this important research.
English
0
0
0
0